These driver mutations are almost always mutually exclusive, making it possible to classify melanoma cases in distinct genomic subtypes: BRAF, RAS, NF1, and Triple-WT, the latter being defined by the absence of BRAF, RAS, and NF1 mutations. This evidence concerns the gene BRAF and melanoma.